← All trials
NCT04313205
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 30, 2020
- Primary completion
- Jul 31, 2020
- Completion date
- Aug 31, 2020
- First posted
- Mar 18, 2020
- Last posted
- Mar 18, 2020
- Enrollment
- 8
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- TaiwanJ Pharmaceuticals Co., LtdLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.